Special Interest

Preoperative Cannabis Abstinence Guidelines (.5 Class A CE with .5 Pharm)

Monday, September 24
10:30 AM - 11:00 AM
Location: Room 312, Hynes

In an effort to provide the safest and best care for patients, providers must weigh the potential harm with the potential benefit for cannabis abstinence. Patients who use cannabis to control other symptoms may face a return of symptoms following a abrupt cannabis cessation. Chronic users may suffer withdrawal symptoms that complicate their perioperative course. Continuation of cannabis therapy regime, except edible preparations, in the preoperative period should be encouraged in the chronic and medical user. Attendees will be given evidence based guidelines to inform anesthetic planning.

Learning Objectives:

JoVanna Eisenbarth, DNAP, CRNA, ARNP, NSPM-C

CRNA
Midwestern University
Olympia, Washington

JoVanna Eisenbarth is a doctoral candidate in Midwestern University’s DNAP program. She graduated in 2006 from Barry University with a MS in Nurse Anesthesia. She is a staff CRNA at Mason General Hospital in Shelton, WA. Eisenbarth has noted the rise in the patients reporting cannabis use, as recreational use was legalized in Washington.

Presentation(s):

Send Email for JoVanna Eisenbarth


Assets

Preoperative Cannabis Abstinence Guidelines (.5 Class A CE with .5 Pharm)

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Preoperative Cannabis Abstinence Guidelines (.5 Class A CE with .5 Pharm)